documents: FDA-2026-N-0746-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-0746-0001 | FDA | FDA-2026-N-0746 | Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program | Notice | 60 Day Proposed Information Collection | 2026-02-20 | 2026 | 2 | 2026-02-20 | 2026-04-22 | 2026-03-14 09:00:11 | 2026-03326 | 1 | 0 | 09000064b91c75af |